Amino Acid Dysregulation Metabotypes Diagnostic for Autism Spectrum Disorder
 /  Posters / Amino Acid Dysregulation Metabotypes Diagnostic for Autism Spectrum Disorder

Amino Acid Dysregulation Metabotypes Diagnostic for Autism Spectrum Disorder

Presented at the American Association of Neurology in Los Angeles, California; April 2018

NeuroPointDX’s autism clinical study, Children’s Autism Metabolome Project (CAMP), is the largest study to identify changes in metabolism associated with autism spectrum disorder (ASD). Over 1,100 children enrolled in the study at eight clinical sites across the United States. NeuroPointDX developed a test panel for metabolic subtypes (metabotypes) associated with ASD.

Related Posts

(608) 441-8187

504 S. Rosa Rd. Suite 150
Madison, WI 53719

contact@NeuroPointDx.com

FOLLOW US